Inevitability and containment of replication errors for eukaryotic genome lengths spanning Megabase to Gigabase by Al Mamun, Mohammed et al.
                                                              
University of Dundee
Inevitability and containment of replication errors for eukaryotic genome lengths
spanning Megabase to Gigabase
Al Mamun, Mohammed; Albergante, Luca; Moreno, Alberto; Carrington, Jamie T.; Blow, John;
Newman, Timothy J.
Published in:







Link to publication in Discovery Research Portal
Citation for published version (APA):
Al Mamun, M., Albergante, L., Moreno, A., Carrington, J. T., Blow, J., & Newman, T. J. (2016). Inevitability and
containment of replication errors for eukaryotic genome lengths spanning Megabase to Gigabase. Proceedings
of the National Academy of Sciences, 113(39), E5765-E5774. DOI: 10.1073/pnas.1603241113
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
 1 
Inevitability and containment of replication errors for eukaryotic 
genome lengths spanning Megabase to Gigabase 
 
Mohammed Al Mamun*, Luca Albergante*, Alberto Moreno, Jamie T. Carrington, J. 
Julian Blow, Timothy J. Newman+. 
 
School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK 
 
* These authors contributed equally 




























Errors in DNA replication can never be completely avoided. By combining a minimal 
model that takes into account the positions of replication origins (the regions on the 
DNA where replication initiates) with experimental evidence, we show that genome 
size strongly influences the frequency of replicative errors. Our work reveals: i) 
simple eukaryotes are able to achieve a very low probability of replicative errors by 
having a moderate number of origins placed at regular intervals, ii) this strategy is 
ineffective in eukaryotes with larger genomes, such as human, for which replicative 
errors are inevitable, and iii) in these organisms even moderate numbers of origins 
can provide containment of replication errors to very low levels, which can be 




The replication of DNA is initiated at particular sites on the genome called replication 
origins (ROs). Understanding the constraints that regulate the distribution of ROs 
across different organisms is fundamental for quantifying the degree of replication 
errors and their downstream consequences. Using a simple probabilistic model we 
generate a set of predictions on the extreme sensitivity of error rates to the distribution 
of ROs, and how this distribution must therefore be tuned for genomes of vastly 
different sizes. As genome size changes from Megabases to Gigabases we predict that 
regularity of RO spacing is lost, that large gaps between ROs dominate error rates but 
are heavily constrained by the mean stalling distance of replication forks, and that for 
genomes spanning ~100 Megabases to ~10 Gigabases errors become increasingly 
inevitable but their number remains very small (three or less). Our theory predicts that 
the number of errors becomes significantly higher for genome sizes greater than ~10 
Gigabases. We test these predictions against datasets in yeast, Arabidopsis, 
Drosophila and human, and also through direct experimentation on two different 
human cell lines. Agreement of theoretical predictions with experiment and datasets is 
found in all cases, resulting in a picture of great simplicity, whereby the density and 
positioning of ROs explain the replication error rates for the entire range of 
eukaryotes for which data is available. The theory highlights three domains of error 
rates: negligible (yeast), tolerable (metazoan) and high (some plants), with the human 






The proper maintenance of genetic information is of fundamental importance to the 
survival of all organisms and many molecular mechanisms exist to ensure that the 
genetic sequence encoded by DNA is maintained unaltered generation after 
generation (1–3). To preserve the integrity of genetic information and to avoid 
aberrant ploidy it is crucial that the entire DNA is copied exactly once: replicating 
only part of the DNA results in potential corruption of genes and replicating certain 
parts of the DNA more than once would perturb chromosome structure and strongly 
affect gene dosage (4–6). Not surprisingly, regions of under- and over-replicated 
DNA are common in cancer (7, 8). 
 
DNA replication is a particularly complex process in eukaryotic organisms with large 
genomes distributed across multiple chromosomes. Multiple checkpoints exist to 
ensure that once replication starts the whole DNA is faithfully replicated before the 
chromosomes are segregated. Under- and over-replication of DNA are prevented by 
using predefined points of replication initiation called Replication Origins (ROs) (3, 
9).  
 
During late mitosis and the G1 phase of the cell division cycle, each potential RO is 
‘licensed’ for a single initiation event by being loaded with MCM2-7 double 
hexamers. In order to prevent re-replication of DNA segments, the ability to license 
new origins ceases before cells enter S phase. During this phase, hundreds to 
thousands of licensed ROs are activated throughout the genome (10). Bidirectional 
replication forks are established at active ROs, each driven by a single MCM2-7 
hexamer, allowing DNA polymerases to copy the DNA (Figure 1a). Despite being 
highly reliable molecular machines, replication forks can on rare occasions 
irreversibly stall (11). The activation of additional ROs can overcome the problem of 
irreversibly stalled replication forks, as a new fork will eventually meet the stalled one 
hence replicating all of the intervening DNA. However, if adjacent right-moving and 
left-moving forks stall and no additional ROs are available between them, the DNA 
in-between the two forks will remain unreplicated (Figure 1b). This phenomenon 
constitutes a major replication error for the cell, which is commonly called a double-
fork stall (DFS) (Figure 1). The occurrence of DFSs is therefore a key obstacle for 
cells to either avoid or overcome in order to maintain replication fidelity. The 
molecular processes underlying the management of DFSs are an active field of study 
and insults to these processes have been associated with different pathologies (11–
13). 
 
In our previous work, we introduced a simple probabilistic theory to determine the 
probability of replication failure arising from DFSs for a given set of ROs in a 
genome (14). The theory depends on two key assumptions, i.e. that the cell has no 
time constraint in completing the process (i.e. that all licensed ROs are allowed to be 
activated as necessary), and that there is a constant small probability per nucleotide 
for each individual replication fork to irreversibly stall. Mathematical analysis of the 
theory showed that in organisms with a genome length comparable to yeasts (~10 
Mbp), evenly distributing the ROs throughout the genome optimally reduces the 
replication errors due to irreversible fork-stalling to levels observed in experiments.  
In accordance with the theoretical prediction, a strong bias towards evenly distributed 
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ROs was observed in biological data derived from different yeast species (14). The 
theory relies on a single unknown parameter, the median stall distance (denoted by 
𝑁𝑠 ), which describes the typical stalling distance of replication forks (RF) in 
eukaryotes (14). Our theory was used to obtain an estimate 𝑁𝑠 from the probability of 
DFS and the RO distribution. The value obtained (𝑁𝑠~12 Mb) is remarkably close to 
direct experimental measurements.  
 
In this article we extend our theory to study much larger genomes (100 Mbp – 10 
Gbp), which are typically found in metazoa and plants. Our theory requires as input 
the positions of ROs along the genome and yields a number of clear predictions 
concerning the rates of DFSs, using both mathematical and computational 
approaches. These predictions were tested on available datasets describing RO 
distribution in one plant (Arabidopsis) (15), one invertebrate (Drosophila) (16) and 
two independent human datasets (reporting different human cell-lines) (17, 18) (SI 
Table 1). Note that the two human datasets have been derived using different 
approaches to RO detection and hence the number and positions of ROs vary between 
them. The two datasets are largely compatible with reported 70% overlap in genomic 
sites containing ROs in both datasets (18) (See also SI Figure 1), and therefore can be 
used to test the robustness of our theory to experimental and biological variation.  
 
Our theoretical and computational analysis leads to a series of direct predictions, 
which are all found to be consistent with all datasets analysed, revealing a picture of 
great simplicity. The robustness of DNA replication in eukaryotes can be maintained 
so long as the largest replicon (inter-RO distance) is well below the median stall 
distance 𝑁𝑠 . For organisms with larger genomes, such as typical vertebrates and 
plants, DFSs are highly likely even if the mean replicon length is small. These 
organisms therefore require mechanisms to deal with DFSs, and in related 
experimental work, we provide experimental evidence for one such post-replicative 
mechanism (19). For cells with such repair mechanisms the burden of equally spacing 
ROs is lifted; far more important is the distribution of larger replicons (relative to 𝑁𝑠) 
from which DFS events are most likely to arise. Our theory also indicates that the 
number of DFSs becomes unwieldy for genomes significantly greater than 10 Gb, and 






The ‘central equation’ for determining replication errors 
 
In our previous work (14) we derived a mathematical equation for the genome-wide 
probability of DFSs, based on the distribution of ROs and the median stalling distance 
𝑁𝑠. The published equations depend on the largest replicon being significantly smaller 
than 𝑁𝑠. Although this limitation holds true for yeast genomes, it does not apply to 
replication origins that have been mapped in mammalian cells. As described in 
Materials and Methods, we use the same theoretical framework to derive more 
general equations that are applicable to genomes containing arbitrarily large replicons. 
In order to utilise our theoretical results we require detailed information on the 
location of ROs. A number of datasets have been published that provide the locations 
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of ROs in eukaryotes along with the total genome length (denoted by 𝑁𝑔  in the 
following). In this work, we have used origin mapping data from Saccharomyces 
cerevisiae (20), Schizosaccharomyces pombe (21), Arabidopsis thaliana (15), 
Drosophila melanogaster (16) and from 5 human tissue culture cell lines (IMR-90, 
HeLa, hESC, iPSC and K562) from Besnard et al. (17) (denoted by ‘B’ in the 
following) and Picard et al. (18) (denoted by ‘P’). Since the work of Picard et al. used 
more modern techniques (particularly in peak identification) it might be considered a 
more reliable dataset; comparison with the Besnard et al. is useful in assessing the 
experimental uncertainties in some of the data. 
 
Because of the very low probability of a DFS in any given replicon, we can show that 
the statistics of DFSs are Poisson to a very high level of accuracy (see SI Text), and 
that the probability of no DFSs genome-wide has the form exp(−𝜆). Thus, a great 
deal of information concerning the probabilities of DFSs for given genome can be 
obtained from the single parameter λ. We remind the reader that for a Poisson 
distribution, λ also describes both the mean and the variance of the distribution. For a 
given genome with K ROs, we denote the replicons by the K-1 values 𝑁𝑖 (with i=1, 
…, K-1). These data can then be used in the ‘central equation’ arising from our theory 
(Eq. 1):  
 
𝜆 =  log(2)
𝑁𝑔
𝑁𝑠






             (Eq. 1) 
 
This expression for λ contains a single unknown parameter 𝑁𝑠 – i.e. the number of 
replicated bases along the DNA beyond which 50% of replication forks irreversibly 
stall. This is inversely proportional to the very small probability of stalling per 
nucleotide (14). 
 
On the right-hand-side of (Eq. 1), we can identify the two distinct contributions of the 
genome length (first term) and of the RO distribution (second term). Genome length 
determines a baseline probability of DFSs that can be lowered by increasing the 
number of ROs and/or changing their distribution along the genome: indeed, as we 
have shown previously (14), for a given number of ROs, equally distributing them 
across the genome is the optimal arrangement to minimize the probability of DFSs. 
This establishes a hierarchy of contributions to the probability of DFSs, with genome 
length being the most important factor, followed by RO number and then RO 
distribution (Figure 2). 
 
In organisms with relatively small genomes, such as yeasts (~10 Mbp), an average 
density of 1 RO per ~20 Kbp allows the maintenance of very small probabilities of 
genome-wide DFSs. Application of (Eq. M11) to the yeast datasets gives values 
around 10-3 for the probability of one or more DFSs, consistent with our previous 
analysis. With the increase in genome size from around 10 Mbp (in yeasts) to around 
10 Gbp (in human), (Eq. M11) shows that the probability of DFSs increases by 
approximately two orders of magnitude, to more than 0.5 for human genomes (Figure 
3a). This huge increase in error rate occurs despite essentially no shift in the mean 
replicon size (Figure 3b). Therefore it is absolutely necessary for these organisms to 




The bias towards uniformly spaced replication origins is progressively lost in 
larger genomes 
 
The regularity of the RO distribution can be assessed by computing the coefficient of 
variation of the replicon lengths, denoted by R, defined as the ratio of their standard 
deviation to their mean. For a perfectly uniform distribution of equally spaced ROs, R 
is equal to 0. On the other hand, computational analysis indicates that when ROs are 
randomly distributed on the genome, the value of R is very close to 1 (14). 
 
In the yeast genomes (diploid genome sizes ~20 Mbp), we previously showed that 
their RO distributions were strongly biased towards uniform spacing with values of R 
ranging from 0.72 to 0.77 (Figure 3c). The probability of DFSs is very small in yeasts 
due to they small genome size, and optimization of the RO positions by lowering R 
reduces this even further. However, as discussed above, organisms with larger 
genomes have a significantly higher probability of DFS events, which results in the 
need for additional molecular mechanisms to cope with the consequences (19) and the 
presence of such mechanisms means there is little to be gained in uniformly ordering 
ROs on the genomes. Thus, our expectation is that R should be significantly larger in 
organisms with larger genomes compared to the values found in yeast. Statistical 
analysis of the available data confirms this expectation (Figure 3c). Arabidopsis and 
Drosophila (diploid genome sizes ~250 Mbp) have values of R around unity (i.e. 
approximating a random distribution). Particularly striking is the fact that in human 
genomes (~6,000 Mbp), the values of R are significantly larger than unity, indicating 
that ROs are not spaced purely randomly and that both the number and size of large 
replicons is significantly greater than expected by chance. This unexpected 
distribution has important consequences that are discussed below. 
 
The probability of a DFS in a given replicon increases with the replicon length 
according to (Eq. M5) (Materials and Methods) and is plotted in Figure 3d. The 
probability has a strongly non-linear form: increasing as the square of the replicon 
length for lengths much less than the stalling distance, and saturating to unity for 
lengths significantly greater than the stalling distance. Figure 3e provides a graphical 
representation that highlights the dramatic shift in variation of replicon lengths, or 
equivalently the per replicon rate of DFS, by plotting the predicted probability of 
DFSs across the largest chromosome of different organisms. It is apparent that the 
variation in probability of error increases by approximately one order of magnitude 
from yeast to Drosophila, and then again by approximately one order of magnitude 
from Drosophila to human. 
 
Large replicons in human genomes cause the most errors but are bounded by the 
stalling distance 
 
Consistent with our analysis of the values of R, we would expect the largest replicons 
in the genome to be very significantly different in diploid genomes of size ~20 Mbp, 
~250 Mbp and ~6 Gbp (represented by yeasts, Drosophila/Arabidopsis and human 
respectively), with significantly larger replicons appearing in those genomes with R 
larger than unity. As seen in Figure 4a, this is exactly what is observed, with the 
largest replicons being ~60 Kbp in yeasts (~120 Kbp expected for a random 
distribution), 151 Kbp in Drosophila (207 Kbp expected if random), 773 Kbp in 
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Arabidopsis (663 Kbp expected if random) and ~5 Mbp in human (~300 Kbp 
expected if random). This can also be seen by the significant increase in outliers in the 
box plots of replicon lengths for the different organisms considered (Figure 4b). As is 
clear from Figure 3d, the probability of a DFS in a given replicon increases 
dramatically as the length of the replicon approaches the median stalling distance 𝑁𝑠. 
To avoid almost inevitable errors arising from a single replicon, we would expect the 
length of the largest replicon in the entire genome to be bounded by 𝑁𝑠, and this is 
indeed what is observed in the data. In the B dataset, we find that the largest replicons 
in each human cell-line are 3.59 Mbp (IMR90), 3.71 Mbp (hESC), 3.71 Mbp (iPSC), 
and 4.29 Mbp (HeLa); while in P we find 5.65 Mbp (IMR90), 5.73 Mbp (HeLa), and 
5.94 Mbp (K562). Interestingly, the largest replicons appear to be bounded by 
approximately one half of the stalling distance, which means that the largest replicon 
in each human cell line contributes a predicted error rate of approximately 5%. We 
note that all the datasets used for our analysis rely on genomic sequencing data. As 
such, large regions of repetitive DNA will not be sequenced accurately, and yet are 
likely to contain ROs. These false negatives imply that the largest replicons measured 
provide an upper bound rather than a definite value, though we do not expect large 
numbers of missed ROs (19). The future use of more advanced techniques, for 
example single cell sequencing, will shed more light on this aspect.  
 
In the human genome, given that errors are very likely, we can determine the range of 
replicon lengths that are the main contributors to the DFS. We grouped the replicons 
into five cohorts: very small (XS; <1 Kbp), small (S; 1-10 Kbp), medium (M; 10-100 
Kbp), large (L; 100 Kbp-1 Mbp) and very large (XL; >1 Mbp). The frequency of 
replicons in these five cohorts is shown for IMR90 from the B and P studies in Figure 
5a and 5b. The most common range of replicons is small and medium respectively, 
the shift from ‘small’ to ‘medium’ being due to the coalescence of small replicons in 
the Picard et al. study. ‘Large’ and ‘very large’ replicons appear only at low 
frequency. Despite this, Figure 5c and 5d show that the cohort of ‘large’ replicons 
dominates as the source of error, which is due to the fact that the DFS probability 
increases non-linearly with the replicon length (Figure 3d). The error rate due to the 
small number of ‘very large’ replicons is significantly smaller compared to the ‘large’ 
replicons. An important consequence of this finding is that there will be a very limited 
impact on genome-wide error rates from false negatives, which primarily affect the 
distribution of ‘very large’ replicons.  
 
Interestingly, in both datasets, for all cell lines a closer examination of the error rates 
in the vicinity of the ‘large’ cohort shows a surprisingly statistically uniform 
distribution of error rate, which is suggestive of ROs being placed so as to “spread the 
risk” of error across size scales. In Figures 5e and 5f, the probability of DFS in each 
10 kbp interval in the range 10 - 300 kbp is shown for the Besnard et al. (Figure 5e) 
and Picard et al. (Figure 5f) datasets for primary IMR90 cells. These are the replicons 
that contribute the most to the DFS probability. The maxima are relatively broad, 
particularly for the B dataset, for which the probability of DFS in each 10kbp is 
approximately constant at 0.030-0.035 across replicons spanning from 40 kbp to 200 
kbp. For replicons significantly smaller than the stalling distance, one can infer from 
the theory that ROs are placed in such a way to give a power law, with a frequency of 
DFSs that decreases as the inverse square of the replicon length thereby spreading the 
probability of a DFS equally amongst all size classes (described by (Eq. M17) in the 
SI Text). Figure 5g and 5h show that there is a remarkable concordance between the 
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theoretical frequency distribution (in blue) with the frequency distribution in the data 
for IMR90 cell-line in both datasets (in red). There is also excellent agreement with 
the theoretical distribution in all the other cell-lines in both datasets (SI Figures 2, 3 
and 4). These results can be interpreted in terms of “spreading the damage” as widely 
as possible in the replicon size region of maximal DFS errors, as a power law is the 
most effective way to delocalize errors from any single cohort of replicon lengths.  
 
Replication errors are common but low in number for higher eukaryotes 
 
As discussed above, our theory predicts that the distribution of the number of DFSs in 
a given genome is Poisson-distributed to a very high degree of accuracy. We have 
applied our theory to the human cell lines datasets to test this prediction. As shown in 
Figure 6, for all cell lines, from both laboratories, the distribution of DFSs is indeed 
Poisson-distributed, regardless of being primary or tumoural cell lines. Statistical 
analysis confirms that the computationally derived probability distribution of DFSs is 
statistically indistinguishable from the fitted Poisson distribution. Interestingly, we 
find a very low probability (<10%) of encountering more than three DFSs in the 
replication of the entire diploid human DNA per cell cycle. Therefore, despite the 
high probability of the presence of DFSs (~80%), in ~90% of cells undergoing DNA 
replication the expected number of DFSs is predicted to be three or less, with one or 
two errors being the most likely occurrences. Indeed, we find that the parameter 𝜆 
(i.e., the mean number of errors) that characterizes the distribution of DFSs ranges 
from 1.67 to 2.15 in Besnard et al. (17) and from 1.21 to 2.05 in Picard et al. (18).  
 
Given that DFSs in human cell lines are almost inevitable, it is somewhat surprising 
to find that their number is quite sharply constrained to be essentially one, two or 
three. This might indicate that the mechanism that deals with such errors has a very 
low capacity. If, as suggested in Moreno et al. (19), the defects induced by DFSs can 
be resolved in the following cell cycle by segregating unreplicated DNA to daughter 
cells, DNA strand breaks could be generated at each DFS. Because the number of 
illegitimate ways that double strand breaks could be correctly rejoined increases as 
the factorial of the number of breaks, this might constrain the number of tolerated 
DFSs to about 3 or less. We provide a rationale for putative biological mechanisms in 
the discussion section, and our arguments lead us to consider two different 
“biomarkers” for double strand breaks which would arise from DFS errors: these are 
the presence of 53BP1 nuclear bodies in the G1 phase of the subsequent cell cycle, 
and the presence of ultrafine anaphase-bridges (UFBs) during mitosis. Our theory 
suggests that the number of both 53BP1 nuclear bodies and UFBs are distributed as a 
Poisson with a value of 𝜆 between one and two. 
 
We have performed an experimental analysis of 53BP1 in IMR90 cells and both 
53BP1 and UFBs in U2-OS cells, and measured the frequency of their occurrence 
during the cell cycle at a single cell level (19). In agreement with our predictions, the 
experimental distributions of both 53BP1 nuclear bodies and UFBs fit to a Poisson 
distribution (Figures 7a, 7b and 7c). Statistical analyses indicate that both a naïve 
fitting using the mean of the data and a more advanced approach that accounts for 
potential errors introduced by the experimental procedure of the immunofluorescence 
experiments (Figures 7a, 7b and 7c) produce distributions which are not statistically 
different from Poisson distributions for both 53BP1 nuclear bodies (P values between 
0.61 and 1 for both IMR90 and U2-OS cells) and UFBs (P values between 0.53 and 1 
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for U2-OS cells). Additionally, the fitted 𝜆 values, 0.52 (naïve) and 0.54 (filtered) in 
IMR90 and 1.64 (naïve) and 1.89 (filtered) in U2-OS cells for 53BP1 nuclear bodies, 
and 1.27 (naïve) and 1.19 (filtered) for UFBs, are in line with the expectation of a 
limited number of DFSs. Moreno et al (2016) (19) show that the number of 53BP1 
nuclear bodies and UFBs follows a Poisson distribution in the HeLa cell line with 𝜆 
values of 0.94 (naïve) and 1.12 (filtered) for 53BP1 and 1.43 (naïve) and 1.19 
(filtered) for UFBs (19). Taken together, these results provide good agreement of our 
theory with the available data and reinforce the connection between 53BP1 nuclear 
bodies and UFBs to DFSs. The analysis of UFBs in unperturbed IMR90 cells was not 
possible due to experimental difficulties related to the fact that this cell line is not 
immortalized.  
 
As a more quantitative analysis, we compared the 𝜆  values obtained by direct 
calculation from the RO distribution of different human cell lines and the 
experimental 𝜆 values estimated from the distribution of 53BP1 and UFBs. Note that 
comprehensive RO distribution data are not available for the cell line used for the 
UFB experiments (U2-OS) and diversity has been observed in RO-distribution across 
different cell lines (17). Moreover, both 53BP1 and UFBs are likely to provide only 
an approximation of the number of DFSs as they appear also in the presence of non-
DFS associated double strand breaks. Despite these limitations, a comparison of the 𝜆 
values indicates that experimental measures are in excellent agreement with 
theoretical prediction (Figure 7d). Additional comparisons with the 𝜆 values obtained 
from HeLa reinforce our conclusions (Figure 7d). Interestingly, the range of variation 
observed in the experimental value of 𝜆 is matched by the range of variation of our 
model predictions, suggesting that our methodology is correctly capturing 
experimental variations. 
 
In both IMR90 and HeLa cells the experimentally derived 𝜆 obtained from 53BP1 
nuclear bodies data is approximately half of the theoretical estimate obtained from the 
RO mapping data. This is also true for UFBs in HeLa cells. So long as the density of 
ROs is small, it is straightforward to show that doubling the density of ROs halves the 
value of 𝜆. Hence the factor of two difference in the experimental and theoretical 
values of 𝜆 could indicate that around half of the genomic ROs are missing in the 
current datasets (e.g. due to difficulties in detecting ROs that fire very rarely or ROs 
positioned in repetitive regions of the DNA). This line of reasoning is also consistent 
with a potential issue with the largest measured replicon being approximately 4 Mbp; 
the issue being that the replication time for such a gap would be significantly longer 
than typical S-phase (ca. 8 hours) (22). If the true RO density is twice that measured, 
one can show that the largest gap would be halved, giving a value of 2 Mbp which is 
in line with the estimate of 2 Mbp for the longest stretch of DNA that could be 
replicated in the duration of S-phase (assuming a fork speed of approximately 2 Kbp 
per minute (23), and remembering that a large replicon will be replicated almost 
symmetrically by forks travelling from either end).  
 
Effect of variation of the stalling distance 
 
In applying our theory to the RO position data for various human cell lines, we can 
vary the numerical value of the median stalling distance 𝑁𝑠 and measure the effect on 
the expected number of DFSs. This allows us to gauge the extent to which our 
conclusions are robust to the variation of the only parameter in our analysis for which 
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we do not have strong experimental data. Both theoretical and biological estimates 
indicate that 𝑁𝑠 is approximately 10 Mbp (14, 24). However, a precise estimate of this 
value is difficult to determine in vivo. The stalling distance is inversely proportional 
to the very small probability of an irreversible stalling event per nucleotide replicated, 
which because of the conservation of the basic replication machinery is likely to be 
relatively well conserved across eukaryotes.  
 
First, we analyzed the overall probability of DFSs occurring as 𝑁𝑠 is varied. In all the 
human cell lines considered we observe a characteristic transition around 5 Mbp: 
below this value the probability of observing DFSs saturates at one (Figure 8a). 
Therefore, DFSs are inevitable for smaller values of 𝑁𝑠  as one might expect. 
Importantly, our analysis indicates diminishing returns when 𝑁𝑠 is increased to much 
larger values: even for 𝑁𝑠 around 30 Mbp, error rates are sufficiently high (1 in 5 cells 
would experience a DFS during S phase) that additional DFS repair mechanisms are 
still required. Therefore, in higher eukaryotes with large genomes the pressure to 
maintain genome stability is most easily resolved by additional safeguard mechanisms 
to deal with consequences of DFSs, rather than by stabilizing the replication 
machinery to give such a large 𝑁𝑠  that DFSs can be avoided with the regular RO 
distribution found in eukaryotes with smaller genomes. 
 
Our analysis stresses the inevitability of DFS errors during replication of the human 
genome and calls for a shift in our approach with respect to how the problem has been 
viewed in the past. On varying the median stalling distance in human cells, the 
probability of exactly one DFS genome-wide reaches a maximum between 10 and 15 
Mbp, depending on the particular cell line and dataset used (Figures 8b and 8c). 
Furthermore, on varying the stalling distance, we find that the probability of exactly 
two or exactly three DFSs occurring also have peaks in the range 6-10 Mbp, again 
depending on the cell line and the dataset used (Figures 8b and 8c). To probe the 
likelihood of small number of errors occurring, we plotted the probability of 
observing one, two or three DFSs as stalling distance was varied (Figures 8d and 8e). 
These results show a very pronounced maximum for 𝑁𝑠 around 10 Mbp in the B 
dataset, and around 8 Mbp in the P dataset. In summary, our analysis of the available 
RO distribution in a variety of human cell lines and in different datasets indicate that 
only for 𝑁𝑠 in the vicinity of 10 Mbp the number of DFSs is constrained between zero 
and three.  
 
Finally, we can measure the average number of DFSs when 𝑁𝑠 is varied. This number 
is equal to the 𝜆 parameter of a Poisson distribution, and therefore allows a direct 
comparison to our experimental measures. As expected, the average number of DFSs 
decreases from a large value as 𝑁𝑠 is increased (Figures 8f and 8g). As explained in 
the previous section, fitting the Poisson distribution to 53BP1 and UFB experimental 
data gives values of 𝜆 between 0.54 and 1.89 (the values are shown in Figure 8f and 
8g as black, blue and red lines). The intersection of the decaying curve with these two 
lines provides another independent estimate of the stalling distance, which we find to 
be between 8 and 16 Mbp depending on the cell line and dataset used. Our analysis of 
the statistics of DFSs in human cell data on varying the stalling distance therefore 
provides very strong evidence for the robustness of this parameter with a value in the 
range 8-15 Mbp, consistent with previous estimates from our analysis of yeast RO 
distributions, and direct experimental estimates (14, 24).  
 
 11 
Effect of varying the number of licensed ROs 
 
Interestingly, amongst the cell types we analysed, there was no major difference in the 
mean replicon length (Figure 3b). Figure 9 shows how decreasing mean replicon 
length would reduce the probability of DFSs in a generic organism. The black, light-
blue, and blue lines illustrate the mean replicon length to achieve a fixed probability 
of DFSs under the optimal situation of equally spaced ROs. All the datasets analyzed 
in the article have a mean replicon length ranging between 10 and 100 Kbp (shaded 
pink in Figure 9). Because of the relatively small genome sizes of yeasts, so long as 
ROs are evenly spaced this mean replicon length can achieve a tolerable DFS 
probability of ~0.1%, similar to the chromosome mis-segregation rate (14). In order to 
maintain a low probability of DFSs as in yeasts, longer genomes would require a 
much lower mean replicon length or in other words, much higher density of ROs on 
the genome. Since the MCM2-7 double hexamer that licenses an RO has a footprint 
of ~60 bp (25, 26) this provides an absolute limit to the possible replicon length 
(dashed line in Figure 9). It is just about possible for organisms with ~6,000 Mbp 
genomes to achieve yeast-like DFS probabilities, but the genome would have to be 
almost completely packed with MCM2-7, which might leave the genome unable to 
perform its major function of providing the template for transcription. Since this is an 
implausible saturation for normal cells, additional post-replicative mechanisms must 
be in place to deal with the inevitable DFSs. For this reason, regularity in RO 






Faithful DNA replication is fundamental to preserve the genetic content of cells and 
to avoid the severe pathologies which arise when DNA is improperly replicated. The 
appropriate location and activation of Replication Origins (ROs) is fundamental to 
ensuring that replicative errors are minimized. Here we show that understanding the 
principles that govern distribution of ROs provides new quantitative insights into the 
way that different organisms maintain genetic integrity. By using a probability theory 
approach, based on a one-parameter model with simple yet plausible assumptions, we 
have developed a set of measures and predictions that further this understanding. The 
excellent agreement of our theoretical predictions with experimental data strongly 
supports the validity of our model assumptions. Moreover, it allows us to explore the 
rich system-level diversity of features and constraints associated with DNA 
replication.  
 
Replicative errors are inevitable in larger genomes 
 
Increased phenotypic complexity of organisms is generally associated with larger 
genome length and metazoans have much larger genomes compared to yeast: the 
diploid human genome is approximately 600 times larger than the haploid yeast 
genome. Despite this large difference in genome size, the replication machinery is 
essentially conserved (4). Over the past few decades, much effort has been devoted to 
understanding the molecular mechanisms involved in eukaryotic DNA replication and 
the associated damage-repair mechanisms. However, less is known about the system-
level structures and processes that allow replication fidelity across the different scales 
of eukaryotic complexity, mirrored by genome lengths spanning over three orders of 
magnitude across yeast to human. We have used a theoretical approach, previously 
validated in yeasts (14), to predict the probability of DFSs for different organisms 
with widely different genome lengths, and for which detailed RO distribution data are 
available.  
 
Our ‘central equation’ shows that there is a hierarchy of contributions to the 
probability of DFS, with genome length being the most important factor, followed by 
RO number and then RO distribution. This effectively creates different classes of 
probabilities of DFS errors (~10-3, ~10-2, and ~1) for the respective classes of 
organisms according to their genome lengths (~20 Mbp, ~250 Mbp and ~6 Gbp). 
Interestingly, amongst the cell types we analysed, there was no major difference in the 
density of ROs i.e. mean replicon length. One possible explanation for this is that in 
order to make a significant effect on reducing DFSs, the RO density in organisms 
with genomes of 250 Mbp or more would lead to excessive clashes with the 
transcriptional machinery. The third component of our equation – the uniformity of 
replicon length, i.e. R – also reflects these classes (with values <1, ~1 and >1 
respectively), indicating that as the probability of DFSs approaches 1 in larger 
genomes, the pressure towards a regular RO distribution is lifted. 
 
Inevitability is mitigated by containment in longer genomes and beyond 
 
DFSs are the primary cause of DNA double strand breaks during replication (27–29), 
and are likely to be major contributors for the development of cancer and other 
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pathologies, such as ones associated with aging (30, 31). The inevitability of DFSs in 
longer genomes requires the presence of cellular mechanisms, which are able to deal 
with such errors in an efficient manner. In related experimental work, we provide 
experimental evidence for one such post-replicative mechanism, involving the 
segregation of unreplicated DNA via UFBs and its protection by 53BP1 before being 
resolved in the next S phase (19). We have demonstrated very good agreement in the 
numbers and statistical distribution of experimental measurements of both 53BP1 and 
UFBs with the predictions of Poisson statistics from our theory, supporting the 
validity of our conclusions, and indicating that DFSs in the experimental systems are 
well approximated as independent events.  
 
Analysis of the data available for human cell-lines within our theoretical framework 
shows that RO density and distribution constrain the number of DFSs per cell cycle to 
three or less for nearly all cells. This may partially be explained by the difficulty in 
properly recombining two strands of DNA when end-joining is used. For example, if 
four DFSs occur and need to be fixed, eight strands will be generated and only one of 
the 24 theoretically possible combinations is correct. From our experimental 
observations, cells with large numbers of 53BP1 nuclear bodies and UFBs showed 
increased blebbing and apoptosis. This suggests that large numbers of DFSs could 
compromise the working of the cell and the efficiency of the repair mechanism. Thus, 
our theory, in light of the experimental data, shows a contingent trade off between 
inevitability of DFS occurrence and the difficulty of its resolution (i.e. apparently 
requiring sophisticated molecular machinery for detection and repair). It is worth 
stressing that our central equation for 𝜆, the mean number of DFSs, contains very 
large numerical values, i.e. 𝑁𝑔  and 𝑁𝑠 , as well as thousands of replicon lengths. 
Therefore, in principle, the formula could have produced values for 𝜆  of almost 
arbitrary magnitude, either much less than or much greater than unity. It is striking 
that our theoretical predictions from the central equation yield values for 𝜆 close to 
unity and in such strong agreement with experimental data. 
 
Another important requirement for the containment of replicative errors in larger 
genomes is an upper limit in the length of large replicons. Longer replicons 
correspond to a higher probability of DFSs (Figure 3d). Our theory indicates that the 
largest tolerable replicons in human cell-lines are bounded by ~0.5 𝑁𝑠 , and 
interestingly the largest replicons found in experimental datasets are around 0.3 𝑁𝑠. In 
addition, we have analysed human cell line data within our theoretical framework, 
and by varying 𝑁𝑠  we are able to clearly show that the probability of observing a 
number of DFSs equal to one, two or three is maximized for 𝑁𝑠 in the region of 10 
Mbp. This value for 𝑁𝑠  is in excellent agreement with previous experimental and 
theoretical estimates in human cell lines and yeasts (14, 24). Due to the universality of 
replication machinery across the eukaryotes and the necessity of error containment in 
larger genomes, we propose this 𝑁𝑠 value to be robust and universal in eukaryotes. A 
further signature of the containment mechanisms associated with the inevitable errors 
in human genomes can be found in the distribution of the risk among replicons of 
different sizes: a relatively narrow range of replicons (of size ~40 to ~200 kbp) 
contributes the most to DFSs, with the different replicon sizes in this range 
contributing approximately equally to the risk.  
 
As a final note, it is worth stressing that some organisms, particularly plants, have 
very large genomes, with 𝑁𝑔 as large as ~100 Gbp (32). Our theory would predict in 
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such cases that the number of DFSs becomes much larger than three, and in the region 
of ten or more. Interestingly it has been observed that the cell cycle length in plants 
undergoes a dramatic lengthening as genome size exceeds about 25 Gb (32), 
potentially reflecting the significantly greater burden of DFS detection and correction 
in these organisms. We would predict similar effects for ploidy variants within the 
same species. We currently do not have genome-wide RO distribution data for these 
organisms to test this idea, but this would provide further opportunities for gaining 
new understanding of the system-level strategies that eukaryotes employ to minimize 
replication errors. 
 
Materials and Methods 
 
1) Experimental setup 
For the 53BP1 and UFBs experiments, U2OS and IMR-90 cell lines from the 
American Type Culture Collection (ATCC) were maintained in Dulbeccos’s Modified 
Eagle’s medium (DMEM, Invitrogen), supplemented with 10% FBS (Invitrogen) and 
penicillin and streptomycin at 37˚C in 5% CO2. Standard immunofluorescence 
protocols were used for the 53BP1 and UFBs staining. Briefly, cells were fixed with 
4% formaldehyde, permeabilised with 0.1% Triton in PBS and blocked in 0.5% fish 
gelatin (Sigma, G-7765). Samples were incubated overnight with primary antibodies. 
To specify G1 phase cells they were incubated with 40 µM EdU (Invitrogen) for 30 
minutes prior to fixation, and then incubated with Cyclin A (abCam, 1:300, ab16726). 
For the detection of 53BP1 cells were also stained with GFP (1:2000, abCam 
ab13970). To stain incorporated nucleotides the Click-iT-EdU kit was used as 
instructed by the manufacturers (Invitrogen, C10337). For staining UFBs, cells were 
incubated with BLM (1:200 Santa Cruz, sc-7790). Alexa secondary antibodies 
(Invitrogen) were used for 1 hour. Microscopy images were acquired using an 
Olympus IX70 deltavision deconvolution microscope and a CCD camera. Data from 
microscopy experiment were analysed using Volocity 3D analysis software (Perkin 
Elmer). 
2) Datasets used and statistical analysis 
 
Limited direct experimental evidence exists on ROs in plants and metazoa and most 
data focus on the genomic density, rather than localization, of ROs (33, 34). 
Therefore, the main results of our article are framed in the context of available 
datasets describing genome-wide RO-positions. Less high-quality datasets have been 
considered where appropriate to provide additional challenge to the theoretical 
predictions and their interpretation. Saccharomyces cerevisiae ROs were obtained 
from the highly curated OriDB (20) with selection criteria discussed in (14). To 
provide additional validation, we considered another yeast species in this article: 
Schizosaccharomyces pombe (21). RO distribution data were also obtained for the 
following multicellular organisms: Arabidopsis thaliana (15), Drosophila 
melanogaster (16) and human. Human data for the four cell lines IMR90, HeLa, 
hESC and iPSC were derived as discussed in (17) and different datasets for IMR90, 
HeLa and K562 cell lines were obtained from (18). The summary of the datasets is 
presented in SI Table 1.  
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When RO positions were defined by genomic ranges, the middle point of the range 
was used as the genomic location of the RO. Moreover, to limit the problems 
associated with technological limitations in sequencing the centromeric regions of 
chromosomes, the largest replicon of each chromosome (corresponding to the 
centromeric region) was excluded from the analysis in all the organisms considered. 
 
Probabilities of DFSs were obtained from RO position data using the formulas 
detailed in the following mathematical derivations. To allowed standardized 
comparisons in computing the probability of DFS, all the organisms were considered 
as diploid. Poisson fits of the computationally derived distribution of DFSs were 
computed using the probability of no DFSs. Poisson fits of the experimental data were 
computed using the mean (naïve) or by minimizing the difference from the 
frequencies of DFS strictly larger than zero (filtered). Differences between 
distributions were computed using Chi-Squared tests. 
 
3) Model derivation and mathematical details 
 
Derivation of central equation 
 
The baseline assumptions that have been used to construct the mathematical model 
have been described elsewhere (14) and will not be discussed here. In yeast the size of 
the largest replicon i.e. inter-RO distance is significantly smaller than 𝑁𝑠. This size 
difference allowed the introduction of approximations, which could be used to obtain 
simpler formulas in our previous work (14). This is not valid in human genomes, and 
therefore we could not rely on the approximations previously used. Hence, various 
quantities had to be re-derived to avoid previously introduced approximations, and we 
provide the more general derivations below. 
 
Let D be the distance between two adjacent ROs located respectively at n = 0 and n = 
N, where N-1 is the number of nucleotides within D. As shown in (14), the probability 
of a double stall in D ‘(DSD)’ is given by the following expression:  
Prob(DSD) = ∑(1 − 𝑞)𝑛𝑞[1 − (1 − 𝑞)𝑁−𝑛]
𝑁−1
𝑛=0
                           (𝑀1) 
Therefore  
Prob(DSD)  =  𝑞 ∑(1 − 𝑞)𝑛
𝑁−1
𝑛=0
 −  𝑞 ∑(1 − 𝑞)𝑛
𝑁−1
𝑛=0
(1 − 𝑞)𝑁−𝑛 
 
                                   =  𝑞 ∑(1 − 𝑞)𝑛
𝑁−1
𝑛=0




Evaluating the sums using the formula for a geometric series we have, 
Prob(DSD)  =   𝑞 (
1 − (1 − 𝑞)𝑁
1 − (1 − 𝑞)
) –  𝑁𝑞 (1 − 𝑞)𝑁 
 
                         =  1 − (1 − 𝑞)𝑁 –  𝑁𝑞 (1 − 𝑞)𝑁 
Thus, 
                     Prob(DSD)  =  1 − (1 + 𝑁𝑞)(1 − 𝑞)𝑁                     (𝑀2) 
 
Expressing the product as the exponential of the sum of the logarithms gives 
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                             (1 − 𝑞)𝑁 = exp(𝑁 log(1 − 𝑞))                                   (𝑀3)         
 
Since q is an extremely small number, log(1 − 𝑞) ≈ −𝑞, and hence  
 
                         (1 − 𝑞)𝑁 = exp(−𝑁𝑞)                                               (𝑀4) 
 
Combining Eq. (M2) with Eq. (M4), we obtain 
 
                 Prob(DSD)  =  1 − (1 +  𝑁𝑞) ⋅ exp(−𝑁𝑞)                 (𝑀5) 
 
Let us define the distance between the adjacent (k+1)th and kth ROs as Nk. The 
probability of double stall between this pair of ROs will be denoted as Pk. 
Thus,  
                   𝑃𝑘  =  1 − (1 +  𝑁𝑘𝑞) exp(−𝑁𝑘𝑞)                               (𝑀6) 
The genome-wide probability of no double stall, which will be denoted as 
Prob(NDS), is given by the product of probability of no double stalls in each replicon, 
i.e. 
                              Prob(NDS)  =  ∏(1 – 𝑃𝑘)
𝑘
                                 (𝑀7) 
Combining Eq. (M6) and Eq. (M7), we have  




}             (𝑀8) 







= exp (−𝑞 ∑ 𝑁𝑘
𝑘
) = exp(−𝑞𝑁𝑔)                    (𝑀9) 
 
Similarly,  
∏(1 +  𝑁𝑘𝑞)
𝑘
= ∏ exp(log(1 + 𝑁𝑘 𝑞))
𝑘
            
= exp (∑ log(1 +  𝑁𝑘 𝑞)
𝑘
)                                       (𝑀10) 
Therefore, combining (M8), (M9) and (M10) we have 
 




Prob(NDS)  = exp (−𝑞 𝑁𝑔  +  ∑ log (1 + 𝑁𝑘 𝑞)
𝑘
) 
Let Ns be the median stalling distance, we have shown before (14) that q =
log(2) /𝑁𝑠. Hence 
   Prob(NDS)  = exp (−
log(2) 𝑁𝑔
𝑁𝑠





)        (𝑀11) 
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As given by Eq. 1 in the main text, where the negative of the quantity in 
parentheses is denoted by λ. Further derivations are provided in the SI Text. 
 
4) Software used 
 





MAM and LA provided original concepts, performed mathematical calculations, 
designed and implemented the computational experiments, analysed the data, and 
wrote the paper. AM provided original concepts, performed some of the biological 
experiments, and wrote the paper. JTC performed some of the biological experiments. 
JJB provided original concepts and wrote the paper. TJN provided original concepts, 
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Figure 1. Potential outcomes arising from ROs licensed on a DNA segment. DNA is 
denoted as a single black line. Prior to S phase entry, four origins (denoted by I, II, III 
and IV) are licensed by binding a double hexamer of Mcm2-7 proteins (blue). As an 
origin fires, both Mcm2-7 single hexamers are converted into an active CMG helicase 
(pink). (a) RO ‘II’ is dormant and passively replicated by the fork coming from RO 
‘I’; replication is complete. (b) Red crosses depict the fork stalling. Previously 
dormant RO ‘II’ is fired to complete the replication of DNA between stalled forks. 
However, as there is no RO licensed between RO ‘III’ and ‘IV’, the DNA between 
two stalled forks in this part remains unreplicated and complete replication is 
compromised. This figure is adapted from previous work (14). 
 
Figure 2: Schematic of the ‘central equation’. The genome length is the dominant 
contributor to the overall replication error due to fork stalling, followed by the 
number of licensed ROs and lastly by their distribution.  
 
Figure 3: a) Predicted probability of one or more DFSs for various eukaryotic 
genomes using the ‘central equation’ from the model. b) Measured mean replicon 
length across the same genomes from the corresponding experimental datasets. c) 
Computed R-values from the same eukaryotic datasets; note, the dashed bars 
represent simulated R-values for virtual genomes of the same length and RO density, 
but assuming ROs to be randomly distributed. d) The probability of a DFS, denoted 
P(DFS), is plotted as a function of increasing replicon length. The estimated median 
fork-stalling distance, 𝑁𝑠  (10 Mbp), is highlighted on the x-axis. P(DFS) starts to 
increase sharply as soon as the replicon size reaches approximately half the value of 
𝑁𝑠; note that the x-axis has a log scale. e) The calculated probability of a DFS inside 
replicons plotted against normalized chromosomal lengths for the largest 
chromosomes in budding yeast, Drosophila, Arabidopsis and the IMR90 cell-line 
from two human datasets (B and P).  
 
Figure 4: a) Measured lengths of the largest replicons are shown in each dataset 
alongside the dashed bars showing the value obtained for virtual genomes of the same 
length and RO density, but assuming ROs to be randomly distributed. b) The 
distribution of genome-wide replicon lengths plotted in boxplot format for budding 
yeast, Drosophila, Arabidopsis and the IMR90 cell-line from two human datasets (B 
and P).   
 
Figure 5: Data in the left and right columns is from the IMR90 human datasets B and 
P respectively. a & b) Frequency of replicons in each cohort; defined according to the 
following size ranges, <103 bp = XS, 103–104 bp = S, 104–105 bp = M, 105–106 bp = 
L, >106  bp = XL. c & d) Probability of DFS in each cohort of the replicons. e & f) 
Higher resolution plot of probability of DFS at the transition from “medium (M)” to 
“large (L)” gap cohorts, contributing most towards the P(DFS); red bars show the bins 
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with maximum P(DFS) in respective datasets. g & h) Theoretical frequency 
distribution of replicons inferred from the plots e & f are presented in blue; grey 
shows the actual frequency distribution in those bins in the data and red highlights the 
red bins in e & f.  
 
Figure 6: Theoretical prediction for the distribution of the number of DFSs based on 
the RO positions in each human cell-line datasets (using data from both B and P); also 
shown, as lines and dots, are best fits to a Poisson distribution. 
 
Figure 7: a) Experimental distribution of three different replicates of 53BP1 nuclear 
bodies in the IMR90 cell-line fitted with a naïve Poisson (i.e. taking the mean of the 
data as 𝜆) (gray) and a filtered Poisson (i.e. ignoring the frequncies of zero counts to 
account for potential error from immunofluorescence staining) (lightgray). The single 
fitting with the average of the three replicates (not statistically different) is shown. b) 
Experimental distribution of 53BP1 nuclear bodies in the U2-OS cell-line fitted with a 
naïve Poisson (i.e. taking the mean of the data as 𝜆) (gray) and a filtered Poisson (i.e. 
ignoring the frequncies of zero counts to account for potential error from 
immunofluorescence staining) (lightgray). c) Experimental distribution of UFBs in the 
U2-OS cell-line fitted with a naïve Poisson (gray) and a filtered Poisson (lightgray). d) 
Values of the Possion parameter 𝜆 obtained from experimental fits of 53BP1 nuclear 
bodies in IMR90, U2-OS and HeLa; and UFBs in U2-OS and HeLa are compared with 
theoretical values obtained from different cell lines in Figure 6. 
 
Figure 8: a) Based on the RO distributions in the various human datasets, theoretical 
predictions of the percentage of cells with DFSs is plotted as a function of the 
parameter 𝑁𝑠 (median stalling distance); the percentage is essentially 100% when 𝑁𝑠 < 
5 Mbp and this percentage is still non-trivially high even when 𝑁𝑠 > 20 Mbp. b & c) 
Theoretical predictions of the probability of one, two and three DFSs is shown as a 
function of 𝑁𝑠. d & e) Theoretical predictions of the probability of one, two, or three 
DFSs is shown as a function of 𝑁𝑠. f & g) Expected numbers of DFSs in different cell-
lines are plotted against 𝑁𝑠; in black, blue and red are the experimentally obtained 
expected number of 53BP1 nuclear bodies in IMR90, U2-OS and HeLa; and UFBs in 
U2-OS and HeLa cell-lines respectively. Crossing points of the black, blue and red 
lines over the curves provide an independent estimate for the plausible range of 𝑁𝑠 
(vertical lines) by directly comparing experimental data with theoretical predictions. 
 
Figure 9: Highlighting the issues faced to maintain small DFS error rates for 
genomes of increasing length: Theoretical prediction of the average replicon length as 
a function of increasing genome length, to maintain a fixed probability of DFS, for 
three different values of this probability; diamonds show the positions of yeast, 
Arabidopsis, Drosophila and human respectively, obtained from the datasets of RO 
positions. The pink shadow highlights the biologically relevant range for mean 
replicon lengths as per all eukaryotic datasets available. The dashed red line marks the 
footprint for the MCM2-7 double hexamer, below which any replicon length is 
biologically unrealistic.  
 
  
